Company Filing History:
1 out of 15 
1 out of 832,912 Years Active: 2000-2009
Title: Mark Tizard – A Pioneer in Mycobacterial Research
Introduction
Mark Tizard is an innovative inventor based in London, GB, known for his contributions to the field of molecular biology and infectious disease research. With two registered patents, Tizard has made a significant impact in the study of pathogenic mycobacteria, particularly concerning advancements in diagnosis and therapy.
Latest Patents
Mark Tizard's latest patents include a significant invention titled "Vector carrying a polynucleotide which encodes a GSD polypeptide from Mycobacterium paratuberculosis." This invention provides a nucleotide sequence representing a pathogenicity island found in species of pathogenic mycobacteria. The islands are represented as SEQ ID NOS: 3 and 4, comprising several open reading frames that encode polypeptides. Tizard's work highlights the use of these polypeptides in both diagnosis and therapeutic applications, showcasing the potential for improved treatments.
Career Highlights
Throughout his career, Mark Tizard has held positions that emphasize his expertise in the medical research field. Notably, he worked at St George's Hospital Medical School, where he contributed to various research projects focused on infectious diseases and their molecular mechanisms. His dedication to understanding complex biological systems has positioned him as a significant figure among inventors in this domain.
Collaborations
Mark Tizard has collaborated with notable researchers, including John Hermon-Taylor and Tim Doran. These partnerships have enriched his work and allowed for the cross-pollination of ideas and expertise, ultimately resulting in advancements that benefit the scientific community and improve public health outcomes.
Conclusion
Mark Tizard's inventive spirit and dedication to research have led to groundbreaking advancements in the field of mycobacterial studies. With his patents focusing on critical areas of infectious disease diagnostics and treatments, Tizard continues to inspire future generations of researchers and innovators in the life sciences.